Jianling Li

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios Α. Dimopoulos, Alessandra Tedeschi, Judith Trotman et al. · New England Journal of Medicine · 2018 · 342 citations · Full text

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

Meletios Α. Dimopoulos, Judith Trotman, Alessandra Tedeschi et al. · The Lancet Oncology · 2016 · 231 citations

Open-label Substudy, Immunology, Clinical Trials +4

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia

Jan A. Burger, Mariela Sivina, Nitin Jain et al. · Blood · 2018 · 219 citations · Full text

Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats

Yong Pan, Yi Wang, Lu Cai et al. · British Journal of Pharmacology · 2012 · 170 citations · Full text

A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions

Jack Yang, Mary Qu Yang, Zuojie Luo et al. · BMC Genomics · 2008 · 87 citations · Full text